Braveheart Bio, Inc. (BRVE)

NASDAQ: BRVE · Real-Time Price · USD

19.55

+0.21 (1.09%)

At close: Oct 15, 2026, 4:00 PM EDT

19.27

-0.28 (-1.43%)

After-hours: Oct 15, 2026, 7:30 PM EDT

Braveheart Bio Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025
Operating Income	-35.4	-4.51
Net Income	-98.46	-66.05
Earnings Per Share	-14.68	-17.20
EPS Growth	-	-

Cash & Debt

Fiscal Year	Current	FY 2025
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025
Net Cash (Debt)	122.26	89.16
Net Cash Growth	-	-
Net Cash Per Share	18.23	23.22
Cash & Investments	122.26	89.16

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025
Operating Cash Flow	-24.15	-2.01
Free Cash Flow	-24.15	-2.01
Free Cash Flow Growth	-	-